Search | IOVS | ARVO Journals

Showing 1 – 20 of 90

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Driving status, avoidance, and visual impairment among older adults in the United States

Shu Xu; Philippa Clarke; Lindsey De Lott; Mickey Nguyen; Joshua R Ehrlich

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4533.

ARVO Annual Meeting Abstract June 2025

Interaction of Vision and Environment on Recurrent Falls

Michelle Sun; Shu Xu; Philippa Clarke; Rachel A. Mumby; Joshua R Ehrlich

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4599.

ARVO Annual Meeting Abstract June 2025

Toward Defining Clinically Relevant Thresholds of Impaired Contrast Sensitivity Among Older U.S. Adults

Mickey Nguyen; Joshua R Ehrlich; Yunshu Zhou; Lindsey De Lott

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4596.

ARVO Annual Meeting Abstract June 2025

Prevalence of vision impairment in rural Nepal: a cross-sectional analysis of the Jirel population

Karthik Reddy; Bhaskar Jha; Pradeep Banjara; Manish Poudel; Joshua R Ehrlich; Suman Thapa

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2061.

ARVO Annual Meeting Abstract June 2025

Census-tract Air Pollution Exposure and Vision Impairment in the National Health and Aging Trends Study

Ambika Mallika Salwan; Patrice Hicks; David Rein; Angela Elam; Philippa Clarke; Lindsey De Lott; Mengyao Hu; Rachel A. Mumby; Joshua R Ehrlich

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2008.

ARVO Annual Meeting Abstract June 2024

Enhancing early glaucoma detection through family screening to reduce glaucoma related blindness

Annamalai Odayappan; Joshua R Ehrlich; Venkatesh Rengaraj; Srinivasan Kavitha; Carroll Webers; Tos TJM Berendschot; Swati Upadhyaya; Sharmila Rajendrababu; Mohideen Abdul Kader; Ganesh Raman; Neethu Mohan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4624.

ARVO Annual Meeting Abstract June 2024

Incidence Patterns of Presenting Visual Impairment among U.S. Older Adults

Joshua R Ehrlich; Lindsey De Lott; Yunshu Zhou; Mengyao Hu; Rachel Mumby; Alan Zheng; Philippa Clarke; Angela Elam; David B Rein

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1841.

ARVO Annual Meeting Abstract June 2024

Cognitive function and vision impairment among the elderly population in residential care in India: The Hyderabad Ocular Morbidity in Elderly Study (HOMES)

Srinivas Marmamula; Thirupathi Reddy Kumbham; Joshua R Ehrlich; David E Bloom; David S Friedman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1839.

ARVO Annual Meeting Abstract June 2024

Association between presenting vision impairment and hospitalization in older U.S. adults

Karolina Leziak; Yunshu Zhou; Rachel Mumby; Mengyao Hu; Lindsey De Lott; David B Rein; Joshua R Ehrlich

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2429.

ARVO Annual Meeting Abstract June 2024

Social determinants of eye health in the United States: a suite of systematic reviews

Leslie Louis; Amudha Aravindhan; Natalia Dellavalle; Joshua R Ehrlich; Angela Elam; Vijay Joshi; Ecosse Luc Lamoureux; Alison Su-Hsun Liu; Mishaal Malik; Paul M Mccann; Riaz Qureshi; Ian Saldanha; Daniel Shaughnessy; Claire Simons; Allison Summers; Tianjing Li

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6001.

ARVO Annual Meeting Abstract June 2023

Exploratory optical coherence tomography (OCT) analysis in patients with geographic atrophy (GA) treated by OpRegen: Results from the Phase 1/2a trial

Eyal Banin; Adiel Barak; David S Boyer; Rita Ehrlich; Allen Ho; Tareq Jaouni; Richard McDonald; Christopher D Riemann; David G Telander; Miao Zhang; Dolly Chang; Avi Ben-Shabat; Gary Hogge; Benjamin Reubinoff

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2826.

ARVO Annual Meeting Abstract June 2023

Associations Between Diabetes, Visual Difficulty, and Economic Well-Being: A Cross-Sectional Analysis of the Health and Retirement Study

Grace Chung; David Flood; Joshua R Ehrlich

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5434.

ARVO Annual Meeting Abstract June 2022

Safety and Efficacy of a Phase 1/2a Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD)

Allen C Ho; Eyal Banin; Adiel Barak; David S Boyer; Rita Ehrlich; Tareq Jaouni; H Richard MacDonald; Christopher D Riemann; David Telander; Jordi Mones; Avi Ben Shabat; Gary S Hogge; Benjamin Reubinoff

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1862.

ARVO Annual Meeting Abstract June 2022

Seeing New Challenges: The Impact of COVID on a Diverse Sample of Adults with Vision Impairment in SE Michigan

Alec Bernard; Sara Weiss; Moshiur Rahman; Joshua D. Stein; Michelle Buck; Marc Thomas; Ann Riddering; Paul A Edwards; Joshua R Ehrlich

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3389 – A0176.

ARVO Annual Meeting Abstract June 2022

Cost-Effectiveness of a School-Based Screening Program in Indonesia for Identifying and Treating Schoolchildren with Refractive Error

Rahul Seshadri Iyengar; Michael Krautmann; Satyaprabha Kotha; John Macom; Nicholas Kourgialis; Joshua R Ehrlich

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2784 – A0114.

ARVO Annual Meeting Abstract June 2022

A Delivery Model for Telemedicine-based Eye Care in Rural Southern India

Sanil Joseph; Vinoth Kumar Rajendran; Dhwanit Khetwani; Mohammed Sithiq Uduman; Dhivya Ramasamy; Gowth Amanulla Mohammed; Kowsalya Akkayasamy; Joshua R Ehrlich; Thulasiraj Ravilla

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1393 – A0089.

ARVO Annual Meeting Abstract June 2022

The Joint Effect of Vision Impairment and Apolipoprotein E on the Hazard of Incident Cognitive Impairment

Joshua R Ehrlich; Ajay Kolli; Yunshu Zhou; Grace Chung; Erin Ware

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2151 – A0179.

Articles October 2021

Demographic, Comorbid, and Clinical Variables Associated With Pointwise Visual Field Damage in Glaucoma: Data From the AGIS and CIGTS Clinical Trials

PDF

Brenda W. Gillespie; Leslie M. Niziol; Joshua R. Ehrlich; Chris A. Johnson; Joseph Caprioli; Paul C. VanVeldhuisen; Paul R. Lichter; David C. Musch
TAGS: comorbidity, demography, glaucoma, visual fields, hypertension, eye, diabetes mellitus, diabetes mellitus, type 2
Trans. Vis. Sci. Tech.. 2021; 10(12):28. https://doi.org/10.1167/tvst.10.12.28

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Phase I/IIa Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD): Interim Results

Christopher D Riemann; Eyal Banin; Adiel Barak; David S Boyer; Rita Ehrlich; Allen Ho; Tareq Jaouni; Richard McDonald; David Telander; Jordi Mones; Joyce Velez; Gary S. Hogge; Benjamin Reubinoff

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3316.

ARVO Annual Meeting Abstract June 2021

Burden of Global Vision Loss Due to Uncorrected Refractive Error: Temporal and Regional Changes 2000-2020

Nathan G Congdon; Joshua R Ehrlich; Serge Resnikoff; Jaimie D Steinmetz; Paul S Briant; Kovin Naidoo; Janet Leasher; Rohit Varma; Jost Jonas; John H Kempen; Tasanee Braithwaite; Hugh R Taylor; Theo Vos; Rupert R A Bourne

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2885.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Driving status, avoidance, and visual impairment among older adults in the United States

Interaction of Vision and Environment on Recurrent Falls

Toward Defining Clinically Relevant Thresholds of Impaired Contrast Sensitivity Among Older U.S. Adults

Prevalence of vision impairment in rural Nepal: a cross-sectional analysis of the Jirel population

Census-tract Air Pollution Exposure and Vision Impairment in the National Health and Aging Trends Study

Enhancing early glaucoma detection through family screening to reduce glaucoma related blindness

Incidence Patterns of Presenting Visual Impairment among U.S. Older Adults

Cognitive function and vision impairment among the elderly population in residential care in India: The Hyderabad Ocular Morbidity in Elderly Study (HOMES)

Association between presenting vision impairment and hospitalization in older U.S. adults

Social determinants of eye health in the United States: a suite of systematic reviews

Exploratory optical coherence tomography (OCT) analysis in patients with geographic atrophy (GA) treated by OpRegen: Results from the Phase 1/2a trial

Associations Between Diabetes, Visual Difficulty, and Economic Well-Being: A Cross-Sectional Analysis of the Health and Retirement Study

Safety and Efficacy of a Phase 1/2a Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD)

Seeing New Challenges: The Impact of COVID on a Diverse Sample of Adults with Vision Impairment in SE Michigan

Cost-Effectiveness of a School-Based Screening Program in Indonesia for Identifying and Treating Schoolchildren with Refractive Error

A Delivery Model for Telemedicine-based Eye Care in Rural Southern India

The Joint Effect of Vision Impairment and Apolipoprotein E on the Hazard of Incident Cognitive Impairment

Demographic, Comorbid, and Clinical Variables Associated With Pointwise Visual Field Damage in Glaucoma: Data From the AGIS and CIGTS Clinical Trials

Phase I/IIa Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD): Interim Results

Burden of Global Vision Loss Due to Uncorrected Refractive Error: Temporal and Regional Changes 2000-2020

To View More...

You must be signed into an individual account to use this feature.